<DOC>
	<DOCNO>NCT01778764</DOCNO>
	<brief_summary>The investigator learn study CyberKnife radiosurgery ( CK RS ) treatment patient 1-3 versus 4 brain metastasis result overall survival . The importance new knowledge determine treatment efficacy CK RS 1-3 versus 4 brain metastasis . The outcome trial would give data support either continuation modification CK RS treatment patient brain metastasis .</brief_summary>
	<brief_title>Phase I Compare OS Post-CyberKnife Radiosurgery Tx 1-3 VS 4 More Brain Metastases</brief_title>
	<detailed_description>This registry-based cohort study patient brain metastasis treat Stanford University Medical Center ( SUMC ) CyberKnife radiosurgery ( CK RS ) . It two component : ( 1 ) retrospective follow-up patient treat since 2006 , ( 2 ) accrual new cohort patient treat 5-year period January 15 , 2013 December 31 , 2017 follow least one year thereafter . The primary aim study estimate effect number brain tumor metastasis survival adjust know risk factor mortality .</detailed_description>
	<criteria>1. presence tumor metastasis tumor metastasis brain manifest neurological examination visibility metastatic lesion ( ) MRI CT scan 2. Karnofsky performance status ( KPS ) score great equal 60 . The exclusion criterion converse , i.e . patient without brain tumor metastasis brain tumor metastases KPS le 60 .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>